This content is in French.
Microbiota & Alcohol: toward a new treatment?
13 janvier 2026
By Ana Espino | Published on January 13, 2026 | 3 min readAlcohol dependence (or alcohol use disorder – AUD) is a major public health problem, responsible for millions of deaths each year. It is frequently comorbid with psychiatric disorders (anxiety, depression) and physical conditions (notably alcoholic liver disease). Despite the availability of medical treatments (disulfiram, naltrexone, acamp
By Ana Espino | Published on January 13, 2026 | 3 min read
Alcohol dependence (or alcohol use disorder – AUD) is a major public health problem, responsible for millions of deaths each year. It is frequently comorbid with psychiatric disorders (anxiety, depression) and physical conditions (notably alcoholic liver disease). Despite the availability of medical treatments (disulfiram, naltrexone, acamprosate) and psychotherapeutic approaches, their effectiveness remains limited, particularly in terms of relapse prevention.
Alcohol dependence (or alcohol use disorder – AUD) is a major public health problem, responsible for millions of deaths each year. It is frequently comorbid with psychiatric disorders (anxiety, depression) and physical conditions (notably alcoholic liver disease). Despite the availability of medical treatments (disulfiram, naltrexone, acamprosate) and psychotherapeutic approaches, their effectiveness remains limited, particularly in terms of relapse prevention.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Wang, S. C., et al. (2020). Alcohol addiction, gut microbiota, and alcoholism treatment: a review. International journal of molecular sciences, 21(17), 6413
View the source
